Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients
Summary
The cell-mediated protective and pathogenic immune responses to SARS-CoV-2 infection remain largely elusive. Here we identified 76 distinct cell subsets in the PBMC samples that were associated with various clinical presentations of COVID-19 using scRNA-seq technology coupled with a deep and comprehensive analysis of unique cell surface markers and differentially expressed genes. We revealed that (TRAV1-2+CD8+)MAIT cells and (NCAM1hiCD160+)NK cells significantly enriched in the asymptomatic subjects whereas (LAG3+CD160+CD8+)NKT cells increased in the symptomatic patients. We also observed that (CD68-CSF1R-IL1BhiCD14+)classical monocytes were positively correlated with the disease severity. Moreover, (CD33-HLA-DMA-CD14+)classical monocytes and (CLEC10A-S100A9lo)pDC were associated with the viral persistence. The GO and KEGG analyses identified enriched pathways related to immune responses, inflammation, and apoptosis. These findings may enhance our understanding of the immunopathogenesis of COVID-19 and help develop novel strategies against SARS-CoV-2 infection.
Overall design
53 peripheral blood mono-nuclear cell (PBMC) samples including 42 COVID-19 patients derived samples and 11 healthy controls (HCs) derived samples
Contributors
Xiaorui Wang†, Han Bai†, Junpeng Ma†, Hongyu Qin†, Qiqi Zeng†, Fang Hu†, Tingting Jiang†, Weikang Mao†, Binghong Zhang✉️, Bingyin Shi✉️, Chengsheng Zhang✉️
Contact
zbhong6288@163.com (Binghong Zhang), shibingy@126.com (Bingyin Shi), cszhang99@126.com (Chengsheng Zhang)
Sample name | Sample title | Disease | Gender | Age | Source | Treatment | Technology | Platform | Omics | Sample ID | Dataset ID | Action |
---|